Form4.ai tracks every SEC insider trade in real time. See every NXTC insider filing with a free account — no card.

See every NXTC insider filing

Free account

NextCure, Inc. (NXTC) Insider Trading

NextCure, Inc. (NXTC) has 2 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $54K, and 1 sales totalling $185K. Most recent filing: Oct. 27, 2026.

Bought vs sold

Open-market value, last 90 days

Bought: $54K (23%) Sold: $185K (77%)
  • Bought $54K · 23%
  • Sold $185K · 77%

What insiders filed

Form 4 filings by type, last 90 days

Buys: 1 (50%) Sales: 1 (50%)
  • Buys 1 · 50%
  • Sales 1 · 50%

At a glance

Insiders trading
2
Largest buy
$54K
Most recent filing
Oct 27, 2026

Latest NXTC Form 4 filings

Date Insider Trade Value Price since buy
Oct 27, 2026 SEC filing ADAR1 Capital Management, LLC 10% Owner Bought $53,691 +19.4% 7D
Aug 12, 2026 SEC filing Simcere Zaiming, Inc. Insider Sold $184,800 —

See every NXTC insider trade

Create a free account to see all 2 NXTC filings from the last 90 days. No card needed.

Create free account

Want NXTC insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.